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TO THE EDITOR
Itch is a common symptom in various
forms of dermatitis characterized by
dry skin, such as senile xerosis and
atopic dermatitis (AD). It is defined as
an unpleasant sensation that provokes
a desire to scratch and, because itch-
elicited scratching aggravates lesions of
the skin, the itch is intensified (Ikoma
et al., 2006). Therefore, reduction of
itching and scratching is an effective
strategy for preventing aggravation
of skin lesions and improving quality
of life. Histamine is the best-known
pruritogen and has been regarded as a
main target for antipruritic therapies,
but H1 receptor (histamine H1R) an-
tagonists are often ineffective against
certain kinds of pruritus including dry
skin pruritus (Wahlgren et al., 1990).
It is suggested that mediators other than
histamine also have a key role in itch;
for example, physiological temperature,
inflammatory mediators, and nitric
oxide. These putative pruritogens are
also recognized as activators of transi-
ent receptor potential (TRP) V3 (Xu
et al., 2002; Hu et al., 2006; Yoshida
et al., 2006), which is a warm-sensitive
Ca2þ -permeable cation channel highly
expressed in epidermal keratinocytes
(Peier et al., 2002). Interestingly, we
indicated previously that a gain-
of-function mutation in TRPV3 caused
itchy dermatitis in rodents (Asakawa
et al., 2006; Yoshioka et al., 2009).
However, we could not sufficiently
suggest a possibility of TRPV3 as a
therapeutic target of pruritus. Hence,
we focused on TRPV3 as a new
therapeutic target for histamine H1R
antagonist–resistant pruritus and carried
out experiments using ICRTRPV3/
mice to determine the maximum thera-
peutic impact of TRPV3 for a certain
type of itch (Inagaki et al., 2001).
The distinguishing feature of
ICRTRPV3/ mice is the presence of
wavy whiskers. Information regarding
TRPV3-knockout mice is shown in
Supplementary Figure S1 online. In
contradiction to previous reports (Moqrich
et al., 2005; Cheng et al., 2010), we did
not find that mice lacking the TRPV3 gene
also exhibit wavy hair coat (data not
shown). This discrepancy may be due,
partially, to the differences in mice
strains used in the different studies.
Recently, Miyamoto et al. (2002)
developed a murine model of dry skin
Abbreviations: AD, atopic dermatitis; AEW, acetone ether water; PGP9.5, protein gene product 9.5;
TRPV3, transient receptor potential vanilloid subfamily 3
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pruritus, which was constructed by
daily treatment of an acetone/ether
(1:1) mixture and water (AEW) applied
to the rostral back, and the resulting
spontaneous scratching of these models
were thought to be histamine-indepen-
dent. By using a modification of this
method, ICRTRPV3/ mice and their
age-matched littermates (ICR TRPV3þ /þ )
were treated with AEW for 4 days to
develop skin dryness and barrier dis-
ruption on their backs. Daily treatment
with AEW increased transepidermal
water loss and decreased stratum cuta-
neous hydration in both ICRTRPV3þ /þ
and ICRTRPV3/ mice (Figure 1a).
Hematoxylin–eosin staining revealed
remarkable epidermal hyperplasia
without infiltration of inflammatory
cells in the dermis in both ICRTRPV3þ /þ
and ICRTRPV3/ mice (Figure 1b). It has
been reported that TRPV3 is required
for the formation of the stratum cor-
neum layer, which is thought to be a
key factor in maintaining skin barrier
functions (Cheng et al., 2010). Contrary
to our expectations, there was no differ-
ence in the manner of the development
of dry skin caused by AEW treatment
between mice with and without TRPV3
in this study. This may be because the
mouse strain used in each study was
different or the effects of AEW treatment
were too strong to detect the effects of
TRPV3 on the development of dry skin.
To examine the impact of TRPV3
deletion on the development of sponta-
neous scratching behavior, we con-
ducted behavioral tests. Repeated
treatment with AEW resulted in a signi-
ficant increase in spontaneous scratching
directed toward the AEW-treated area,
which was suppressed by subcutaneous
injections of naltrexone, a m-opioid
receptor antagonist (Figure 2b). Given
that m-opioid receptor antagonists
reduce experimentally induced itch in
humans (Heyer et al., 1997), sponta-
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Figure 1. Physiological and histological features of experimental dry skin induced by acetone ether water (AEW) in ICRTRPV3þ /þ and ICRTRPV3/ mice.
(a) Skin dryness and barrier disruption after acetone treatment were determined by measuring transepidermal water loss (TEWL) for 30 seconds using a Tewameter
TM210 (Courage & Khazawa, Cologne, Germany) or stratum corneum hydration expressed as relative capacitance (RC) using Moisture checker MY-808S
(Scalar, Tokyo, Japan). The method of AEW treatment is as follows. The hair of mice was shaved over the rostral part of the back at least 4 days before the start
of the experiment. The skin was treated by applying a piece of cotton soaked with a mixture of acetone and diethylether (1:1(v/v)) directly onto the shaved
area for 15 seconds, followed immediately by application of a piece of cotton soaked with distilled water to the exact same skin area for 30 seconds. AEW
treatments were performed twice daily for four consecutive days. Each value represents mean±SEM for eight mice. (b) The dorsal skin was excised and fixed
with 10% neutral formalin, embedded in paraffin, and sectioned at 4mm. Sections were stained with hematoxylin–eosin. Bar¼100mm. NS, not significant.
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neous scratching behavior observed in
the AEW-treated mice might reflect
similar itch sensation in humans. In
the AEW-treated ICRTRPV3/ mice,
there was no increase in the types of
scratching behaviors compared with
those without AEW-treatment (Figure 2c).
To rule out the possibility of a sedative
effect, we also measured the sponta-
neous motor activity and could not find
any locomotor effects evoked by TRPV3
deletion in these mice (Figure 2a). These
results indicated that TRPV3 has a pivotal
role in the development of itch in mice
with dry skin.
It is well known that increased nerve
density is involved in producing prur-
itus. In AD patients, increased sprouting
of epidermal C-fibers is seen, inducing
hypersensitivity to itching, which
aggravates the disease (Paus et al.,
2006). In the present study, we also
found that the density of the invasive
nerve fibers in the skin was increased
in AEW-treated mice, as observed by
immunohistochemical examination of
the sensory neurons using anti-protein
gene product 9.5 (PGP9.5) antibody
(Figure 3). PGP9.5-positive neurites in
the dermis were more prominent in the
AEW-treated skin of wild-type mice
compared with that of ICRTRPV3/
mice, and some fibers expanded into
the epidermal layer. These results sug-
gested that TRPV3 affected nerve
sprouting in dry skin. Previous studies
indicate that TRPV3 affects the produc-
tion of epidermal nerve growth factor
(Gopinath et al., 2005; Yoshioka et al.,
2009), which suggests that TRPV3
causes pruritus in lesional skin through
nerve fiber expansion. In AD patients
with pruritus, higher expressions of
TRPV3 messenger RNA are observed
compared with those without pruritus
(data not shown). This suggests that
TPPV3 is involved in human and
murine pruritus in a similar manner.
Although we could not carry out
pharmacological studies using TRPV3
antagonists to elucidate the therapeutic
role of TRPV3 for a certain type of
pruritus, we believe that this is the first
report referring to their role by genetic
studies using ICRTRPV3/ mice. TRPV3
may have an important role in dry skin
itch, and TRPV3 antagonists could be a
therapeutic option in managing AD and
dry skin patients with histamine H1R
antagonist–resistant pruritus.
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Figure 2. Spontaneous scratching induced by acetone ether water (AEW) and locomotor activity in ICRTRPV3þ /þ and ICRTRPV3/ mice. (a) Behavior was
measured over a 6-hour period as the amount of spontaneous motor activity in both mice strains using Activity Sensor Model NS-AS01 (NeuroScience, Tokyo,
Japan). Each value represents mean±SEM for 8–16 mice. (b) Scratching behavior of ICR mice with and without AEW treatments was evaluated during a 2-hour
observation period. Naltrexone (NTX, 10 mg/kg) was dissolved in saline and injected subcutaneously 15 minutes before behavioral observation. Each value
represents mean±SEM for 8–16 mice. (c) Scratching behavior of ICRTRPV3þ /þ and ICRTRPV3/ mice with and without AEW treatments was evaluated during a
2-hour observation period. Each value represents mean±SEM for 8–16 mice. **Po0.01 when compared with control (CONT), ##Po0.01 when compared with
saline (SAL). NS, not significant (Student’s t-test).
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Figure 3. Lower nerve response to acetone ether water (AEW) treatment in the skin of ICRTRPV3/
mice. Frozen sections were prepared from dorsal skin samples obtained from ICRTRPV3þ /þ and
ICRTRPV3/ mice and immunostained for mouse protein gene product 9.5 (PGP9.5). Arrows indicate
PGP9.5-expressing neurites. Bar¼ 100mm.
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TO THE EDITOR
Ascorbic acid (AA) acts as an electron
donor to reduce reactive oxygen
species and also acts as a cofactor for
hydroxylation of procollagen (Peter-
kofsky and Udenfriend, 1965; Bielski
et al., 1975; Nishikimi, 1975). In
addition to these functions, AA has
another beneficial effect on the skin.
AA protects keratinocytes from reactive
oxygen species–mediated damage after
UVB irradiation in vitro (Stewart et al.,
1996). However, the effect of an AA
deficiency on skin, especially the epi-
dermis, is not yet clear.
Hairless mice are commonly con-
sidered to be a valuable animal model
for skin research. However, previously
established lines of hairless animals,
such as mice, effectively synthesize
AA in vivo. Previously, we identified
that senescence marker protein-30
(SMP30) was a gluconolactonase
(GNL), the essential enzyme of the
AA synthesis pathway (Kondo et al.,
2006). In addition, SMP30/GNL
knockout mice developed symptoms
of scurvy when fed an AA-deficient
diet. To clarify the pivotal role of AA in
the skin, we mated SMP30/GNL
knockout mice with hairless mice
and established a new strain of
SMP30/GNL knockout hairless mice.
The features of this new strain are
hairlessness and incapability of syn-
thesizing AA in vivo. Because mice
of this strain have black eyes, black
ears, and a black tail, they look like a
devil and hence are called ‘‘devil
mice’’ (Figure 1a). In the present study
of our newly developed devil mice,
we proved that AA depletion of the
skin leads to epidermal atrophy and
UVB-induced skin pigmentation.
A detailed description of procedures
is provided in Supplementary Materials
and Methods online. Five-week-old
devil mice were divided into following
four groups: AA supplemented (AA
(þ )), AA deficient (AA ()), UVB irra-
diatedþAA supplemented (UVB AA
(þ )), and UVB irradiatedþAA defi-
cient (UVB AA ()). This AA supple-
mentation was enough to maintain
Abbreviations: AA, ascorbic acid; GNL, gluconolactonase; HE, hematoxylin–eosin; SMP30, senescence
marker protein-30
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